Business
Hyperfine, Liminal Sciences, and HealthCor Catalio Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
GUILFORD, Conn., Nov. 29, 2021 /PRNewswire/ -- Hyperfine, Inc. ("Hyperfine"), creator of the first FDA-cleared portable magnetic resonance imaging (MRI)
About this update from Hyperfine, Inc.
[{"type":"text","content":"GUILFORD, Conn., Nov. 29, 2021 /PRNewswire/ -- Hyperfine, Inc. (\"Hyperfine\"), creator of the first FDA-cleared portable magnetic resonance imaging (MRI) device, Swoop®, Liminal Sciences, Inc. (\"Liminal\"), a medical device development company dedicated to non-invasive measurement of key vital signs in the brain, and HealthCor Catalio Acquisition Corp. (\"HealthCor\"), a healthcare-focused special purpose acquisition company (SPAC), today announced that the Securities and Exchange Commission (\"SEC\") has declared the Registration Statement on Form S-4 in connection with the proposed business combination between the companies to be effective.\n\n \n \n \n \n \n \n\n \nAn extraordinary general meeting of HealthCor shareholders (the \"Special Meeting\") to approve, among other things, the proposed business combination, will be held at the offices of Kirkland & Ellis LLP, 609 Main Street, Suite 4700, Houston, Texas 77002 on December 21, 2021 at 10:00 a.m. Eastern Time. Shareholders may also attend the Special Meeting and vote their shares electronically during the Special Meeting via live webcast by visiting https://www.cstproxy.com/hcspac/2021. HealthCor also announced today that it has filed with the SEC a definitive proxy statement/prospectus relating to the Special Meeting, and will commence mailing it on or about November 30, 2021 to its shareholders of record as of the close of business on November 4, 2021.\nAbout Hyperfine and the Swoop® Portable MRI System\nHyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. The company's Swoop® Portable MR Imaging System™ is designed to address the limitations of current imaging technologies and make MRI accessible anytime, anywhere, to any patient. Swoop wheels directly to the patient's bedside, plugs into a standard electrical wall outlet, and is controlled by an Apple iPad®. Designed as a complementary system to traditional MRIs at a fraction of the cost, images that display the internal structure of the head are captured by Swoop at the patient's bedside, with results in minutes, enabling life-saving decision-making capabilities across a variety of clinical settings.\nHyperfine received FDA clearance for its portable MRI for the brain and head of patients of all ages in August 2020. Since its launch in the fall ...